Header cover image

Polish (WIG) Biotech Industry Analysis

UpdatedMar 18, 2024
DataAggregated Company Financials
Companies13
  • 7D-0.3%
  • 3M-9.5%
  • 1Y-14.2%
  • YTD-9.3%

Over the last 7 days, the Biotech industry has remained flat, although notably Synthaverse gained 5.4%. Unfortunately though, the industry is down 14% over the past 12 months. As for the next few years, earnings are expected to grow by 39% per annum.

Industry Valuation and Performance

Has the Polish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 19 Mar 2024zł2.2bzł462.1m-zł74,341,007.0061.6x-30x4.8x
Thu, 15 Feb 2024zł2.3bzł461.4m-zł75,137,486.00122.6x-31.1x5.1x
Sat, 13 Jan 2024zł2.8bzł499.9m-zł66,755,911.0092.1x-41.7x5.6x
Mon, 11 Dec 2023zł2.7bzł499.9m-zł66,755,911.0089.7x-40.3x5.4x
Wed, 08 Nov 2023zł2.6bzł511.7m-zł63,340,678.0045.8x-41.7x5.2x
Fri, 06 Oct 2023zł2.7bzł518.4m-zł60,858,678.0048.1x-44.3x5.2x
Sun, 03 Sep 2023zł2.8bzł521.0m-zł47,585,668.0051.8x-59.7x5.4x
Tue, 01 Aug 2023zł2.9bzł520.7m-zł42,515,291.0053.7x-68.5x5.6x
Thu, 29 Jun 2023zł2.8bzł520.7m-zł42,515,291.0054.7x-66.9x5.5x
Sat, 27 May 2023zł2.9bzł521.5m-zł43,847,569.0066.9x-66.3x5.6x
Mon, 24 Apr 2023zł2.9bzł528.2m-zł13,228,449.0065.3x-218.3x5.5x
Wed, 22 Mar 2023zł2.7bzł488.6m-zł16,165,349.0059.3x-168.4x5.6x
Fri, 17 Feb 2023zł2.9bzł488.3m-zł16,058,853.0060.2x-182x6x
Sun, 15 Jan 2023zł2.9bzł496.5m-zł10,783,764.0048.3x-273.2x5.9x
Tue, 13 Dec 2022zł2.7bzł496.5m-zł10,783,764.0046.8x-254.1x5.5x
Thu, 10 Nov 2022zł2.7bzł460.6m-zł17,905,868.0046.6x-150.6x5.9x
Sat, 08 Oct 2022zł2.5bzł444.0m-zł13,473,868.0058.4x-186.4x5.7x
Mon, 05 Sep 2022zł2.8bzł401.8m-zł16,662,258.0060.9x-169.2x7x
Wed, 03 Aug 2022zł2.8bzł472.9mzł66,686.0027.2x41946.7x5.9x
Fri, 01 Jul 2022zł2.3bzł472.9mzł66,686.0024.9x34493.3x4.9x
Sun, 29 May 2022zł2.5bzł426.5mzł14.0m34.9x175.4x5.8x
Tue, 26 Apr 2022zł2.7bzł369.1m-zł37,778,677.0036.2x-71x7.3x
Thu, 24 Mar 2022zł2.8bzł348.8m-zł40,884,677.0033.1x-67.7x7.9x
Sat, 19 Feb 2022zł3.1bzł348.8m-zł40,884,677.0036.1x-75x8.8x
Mon, 17 Jan 2022zł3.6bzł369.9m-zł24,922,742.0050.4x-146.2x9.9x
Wed, 15 Dec 2021zł3.8bzł369.9m-zł24,922,742.0049.2x-151.4x10.2x
Fri, 12 Nov 2021zł3.6bzł367.1mzł91,715.0034.7x38943.6x9.7x
Sun, 10 Oct 2021zł3.8bzł364.5m-zł1,455,285.0033.3x-2640.8x10.5x
Tue, 07 Sep 2021zł3.6bzł364.5m-zł1,456,285.0038.8x-2489.4x9.9x
Thu, 05 Aug 2021zł3.6bzł362.9m-zł8,912,285.0040.3x-407.7x10x
Sun, 09 May 2021zł3.8bzł373.1m-zł6,705,220.00122x-571.3x10.3x
Price to Earnings Ratio

-533.9x


Total Market Cap: zł3.6bTotal Earnings: -zł6,705,220.00Total Revenue: zł373.1mTotal Market Cap vs Earnings and Revenue0%0%0%
Polish Biotech Industry Price to Earnings3Y Average 1482.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Polish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.1x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 7.4% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Polish Healthcare industry?

PL Market0.021%
Healthcare0.74%
Biotech-0.35%
Biotech-0.35%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PTG Poltregzł55.805.3%
+zł13.1m
5.3%PS173.6x
MAB Mabionzł16.663.1%
+zł8.1m
-7.5%PE4.6x
SVE Synthaversezł3.930.8%
+zł2.3m
-30.8%PE80.1x
GX1 genXonezł8.348.6%
+zł2.2m
-2.2%PS11.5x
GEN Genomed Spólka Akcyjnazł29.600.7%
+zł264.3k
-22.1%PE39.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PTG

zł55.80

Poltreg

7D

5.3%

1Y

5.3%

GEN

zł29.60

Genomed Spólka Akcyjna

7D

0.7%

1Y

-22.1%

GX1

zł8.34

genXone

7D

8.6%

1Y

-2.2%

MAB

zł16.66

Mabion

7D

3.1%

1Y

-7.5%

SVE

zł3.93

Synthaverse

7D

0.8%

1Y

-30.8%

PUR

zł8.23

Pure Biologics

7D

-10.5%

1Y

-55.0%

GMT

zł10.55

Genomtec

7D

-4.1%

1Y

12.2%

BCX

zł88.40

Bioceltix

7D

-1.6%

1Y

103.2%

URT

zł95.00

Urteste

7D

-4.0%

1Y

-34.5%